PALEARI, RENATA
 Distribuzione geografica
Continente #
EU - Europa 4.580
NA - Nord America 2.326
AS - Asia 1.646
AF - Africa 88
SA - Sud America 65
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.717
Nazione #
US - Stati Uniti d'America 2.267
IT - Italia 1.609
GB - Regno Unito 1.363
CN - Cina 686
SE - Svezia 327
SG - Singapore 288
DE - Germania 265
RU - Federazione Russa 224
IN - India 181
TR - Turchia 181
IE - Irlanda 153
KR - Corea 136
UA - Ucraina 123
FR - Francia 113
FI - Finlandia 84
NL - Olanda 80
NG - Nigeria 61
EU - Europa 59
DK - Danimarca 57
CA - Canada 51
ID - Indonesia 38
CO - Colombia 36
BE - Belgio 30
GR - Grecia 30
HK - Hong Kong 30
JP - Giappone 28
PL - Polonia 24
CH - Svizzera 21
RO - Romania 21
PT - Portogallo 19
VN - Vietnam 16
BR - Brasile 15
TH - Thailandia 13
AU - Australia 10
CZ - Repubblica Ceca 10
TW - Taiwan 10
IR - Iran 9
MY - Malesia 7
AR - Argentina 6
ES - Italia 6
MX - Messico 6
BD - Bangladesh 4
PH - Filippine 4
SA - Arabia Saudita 4
SC - Seychelles 4
AT - Austria 3
CL - Cile 3
DZ - Algeria 3
PK - Pakistan 3
TN - Tunisia 3
ZA - Sudafrica 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
EC - Ecuador 2
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
LV - Lettonia 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
PE - Perù 2
SD - Sudan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BF - Burkina Faso 1
BJ - Benin 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CM - Camerun 1
EE - Estonia 1
EG - Egitto 1
GH - Ghana 1
HU - Ungheria 1
IQ - Iraq 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MT - Malta 1
PA - Panama 1
QA - Qatar 1
RW - Ruanda 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
VG - Isole Vergini Britanniche 1
Totale 8.775
Città #
Southend 1.294
Milan 248
Seattle 209
Princeton 184
Singapore 179
Chandler 165
Dublin 148
Beijing 135
Wilmington 124
Mountain View 118
Redmond 92
Ann Arbor 83
Jacksonville 83
Nanjing 82
Dearborn 74
Fairfield 72
Houston 71
Des Moines 65
Lekki 55
Sakarya 53
Rome 51
Bengaluru 46
Toronto 43
Ashburn 42
Boardman 41
Shenyang 36
Woodbridge 36
Frankfurt am Main 35
Jinan 34
Andover 33
Bogotá 31
Santa Clara 31
Serra 31
Redwood City 30
Guangzhou 27
Athens 26
Nanchang 25
Phoenix 25
Tianjin 25
Cagliari 24
Jakarta 22
Hangzhou 21
Napoli 21
Helsinki 20
Hebei 19
Berlin 18
Chicago 18
Hong Kong 18
Istanbul 18
New York 18
Somerville 18
Brussels 17
Changsha 17
Warsaw 17
Bologna 16
Shanghai 16
Zhengzhou 16
Naples 15
Roxbury 15
Bühl 14
Cambridge 13
Fuzhou 13
Jiaxing 13
Eitensheim 12
Porto 12
San Diego 12
Seoul 12
Bari 11
Ningbo 11
Sassari 11
Tokyo 11
Hanover 10
Kunming 10
Parma 10
Turin 10
Wuhan 10
Caserta 9
Catania 9
Crespano Del Grappa 9
Dong Ket 9
Odernheim 9
Torino 9
Verona 9
Waanrode 9
Falls Church 8
Hefei 8
Lisbon 8
Padova 8
Sunnyvale 8
Trieste 8
Agrigento 7
Bitonto 7
Ferrara 7
Florence 7
Haikou 7
Rho 7
Taiyuan 7
Taranto 7
Arona 6
Brescia 6
Totale 4.929
Nome #
Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma 521
Refertazione dell'emoglobina glicata in presenza di varianti emoglobiniche 393
Anemia a cellule falciformi e sindromi correlate: aggiornamenti e prospettive 372
Albumina glicata : un indice di controllo glicemico da rivalutare 300
Valutazione multicentrica dell'analizzatore Tosoh G8 per la misura dell'emoglobina A2 e dell'emoglobina F 259
Raccomandazioni per l’esecuzione della Curva Standard da Carico Orale di Glucosio (OGTT) per la diagnosi di Diabete Mellito 236
Analysis of red cell membrane proteins by capillary gel electrophoresis 191
Valutazione della commutabilità per il sistema analitico Cobas Integra dei materiali di controllo utilizzati nella VEQ per l’emoglobina glicata 176
Utilità clinica della misura dell’emoglobina fetale 145
Analytical evaluation of the Tosoh HLC-723 G7 automated HPLC analyzer for hemoglobin A2 and F determination 140
Placental antioxidant defenses and autophagy-related genes in maternal obesity and gestational diabetes mellitus 137
La determinazione dell'emoglobina A2 nel sangue : attualità e prospettive 135
CHROMATOFOCUSING AND ISOELECTRIC-FOCUSING IN IMMOBILIZED PH GRADIENTS COMPARED FOR CHARACTERIZATION OF HUMAN-HEMOGLOBIN VARIANTS 130
I "microarray" a proteine per una medicina personalizzata 129
Automated HPLC analysis can lead to successful prevention of severe Thalassemia diseases 127
Revaluation of biological variation of HbA1c using an accurately designed protocol 127
Determination of HbA2 by quantitative bottom-up proteomics and isotope dilution mass spectrometry 127
Applicazioni dell'elettroforesi capillare all'analisi delle proteine della membrana eritrocitaria 125
The First Case of Hb G-Honolulu [α30(B11)Glu→Gln (GAG>CAG); HBA2:c.91G>A] Observed in Association with Hb S [β6(A3)Glu→Val, GAG>GTG] in a Healthy Italian Child 121
Characterization of Hb Camperdown [beta 104(G6)Arg-->Ser] by capillary electrophoresis and automated solid phase DNA sequencing 119
A patient-side technique for real-time measurement of acetylcholinesterase activity during monitoring of eptastigmine treatment 116
Effects of different anticoagulants on glycated albumin quantification 115
Il deficit di G6PD in Medicina di Laboratorio = G6PD deficiency in Laboratory Medicine 115
Analytical goals for the determination of HbA₂ 114
EurA1c: The European HbA1c trial to investigate the performance of HbA1c assays in 2166 laboratories across 17 countries and 24 manufacturers by use of the IFCC model for quality targets 109
Standardization schemes for hemoglobin A1c determination 108
Role of fructosamine-3-kinase in protecting against the onset of microvascular and macrovascular complications in patients with T2DM 107
Reference intervals for hemoglobin A1c in pregnant women : data from an Italian multicenter study 106
Revaluation of biological variation of glycated haemoglobin (HbA1c) using an accurately designed protocol and an assay traceable to the IFCC reference system 101
The role of haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies 100
Biological variability of albumin excretion rate and albumin to creatinine ratio in hypertensive type 2 diabetic patients 99
The relevance of hemoglobin F measurement in the diagnosis of thalassemias and related hemoglobinopathies 99
Standardization of the HbA2 assay 99
Standardizzazione dell’emoglobina glicata nell’ambito dello studio DAI 95
A re-evaluation of glycohemoglobin standardization : the Italian experience with 119 laboratories and 12 methods 94
External quality assessment of hemoglobin A2 measurement : data from an Italian pilot study with fresh whole blood samples and commercial HPLC systems 93
Double heterozygosity for hemoglobin Malmö [beta 97 (FG 4) His-->Gln] and beta-thalassemia traits 93
G6PD/PK ratio : a reliable parameter to identify glucose-6-phosphate dehydrogenase deficiency associated with microcytic anemia in heterozygous subjects 92
The analytical performance of laboratory plasma glucose and HbA1c measurements are largely acceptable 92
Reference range for HbA1c in pregnancy 91
Can plasma glucose and HbA1c predict fetal growth in mothers with different glucose tolerance levels? 88
Sources and performance criteria of uncertainty of reference measurement procedures 88
Reference intervals for acetylated fetal hemoglobin in healthy newborns 87
Experiences in the measurement of RBC-bound IgG as markers of cell age 86
null 85
A roadmap for the standardization of hemoglobin A(2) 85
New analytical tools and epidemiological data for the identification of HbA2 borderline subjects in the screening for beta-thalassemia 84
Commutability of control materials in glycohemoglobin determinations 84
Posttranslational deamidation of proteins: the case of hemoglobin J Sardegna [alpha50(CD8)His->Asn->Asp] 83
Towards the development of a certified reference material for hemoglobin A2 83
Esperienze pilota sulla Valutazione Esterna di Qualità della misura dell’emoglobina A2 con campioni di sangue intero e metodiche HPLC commerciali 82
Hb Abruzzo [beta 143(H21)His-->Arg] identified by mass spectrometry and DNA analysis 81
IHP entrapment into human erythrocytes: comparison between hypotonic dialysis and DMSO osmotic pulse 79
Determinazione della variabilità biologica dell'emoglobina A2 79
Preliminary experience with the differential pH technique for glucose-6-phosphate dehydrogenase (G6PD) measurement in whole blood: application to an area with high prevalence of thalassaemia and G6PD deficiency 78
Hb Puttelange [alpha140(H19)Ala->Val] in an Itallian man with polycythemia 77
An evaluation of the Diamat HPLC analyser for simultaneous determination of haemoglobins A(2) and F 77
Evaluation of the analytic performances of the new HPLC system HLC-723 G7 for the measurement of hemoglobin A1c 75
Clinical utility of fractionating erythrocytes into "Percoll" density gradients 74
Pharmacodynamic monitoring of eptastigmine in capillary blood 72
Genetic variability of the fructosamine 3-kinase gene in diabetic patients 71
Interlaboratory comparison of current high-performance methods for HbA(2) 70
Simultaneous automated determination of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities in whole blood 69
Calibration by commutable control materials is able to reduce inter-method differences of current high-performance methods for HbA2 69
Malattia renale nel diabete: oltre la nefropatia diabetica = Kidney disease in diabetes : beyond diabetic nephropathy 69
Preparation and control of ethylene glycol-stabilized haemolysates for glycated haemoglobin assay 67
Developing a reference system for the IFCC standardization of HbA2 65
Rapid determination of erythrocyte pyruvate kinase activity 64
Possible role of fructosamine 3-kinase genotyping for the management of diabetic patients 63
Evaluation of biological variation of glycated albumin (GA) and fructosamine in healthy subjects 61
Performance of the Architect enzymatic assay for HbA1c 61
Quantitative IHP determination by 31P-NMR: proposal for a standardized protocol 60
Limits to the use of the glucose 6-phosphate dehydrogenase/6-phosphogluconate dehydrogenase index for the detection of glucose 6-phosphate dehydrogenase deficiency 59
More on the accuracy of the Architect enzymatic assay for hemoglobin A1c and its traceability to the IFCC reference system 57
The role of socio-economic and clinical factors on HbA1c in children and adolescents with type 1 diabetes : an Italian multicentre survey 57
Esperienza in un presidio antidiabetico ospedaliero con un metodo point-of-care per la determinazione dell'emoglobina glicata 55
Inter-method differences and commutability of control materials for HbA2 measurement 54
Valutazione del sistema Capillarys 2 Flex Piercing per la misura dell'emoglobina A1c = Evaluation of the Capillarys 2 Flex Piercing system for the determination of hemoglobin A1c (HbA1c) 54
Characterization of Maternal Circulating MicroRNAs in Obese Pregnancies and Gestational Diabetes Mellitus 51
A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial 50
Performance of glycated hemoglobin (HbA1c) methods evaluated with EQAS studies using fresh blood samples : still space for improvements 46
Multicenter evaluation of an enzymatic method for glycated albumin 44
Il progetto pilota SIBioC di VEQ della misura dell'emoglobina glicata = Pilot SIBioC EQAS project on glycated hemoglobin measurement 42
Topical nerve growth factor prevents neurodegenerative and vascular stages of diabetic retinopathy 41
Joint Committee for Traceability in Laboratory Medicine (JCTLM): una cooperazione internazionale per promuovere la standardizzazione dei risultati in Medicina di Laboratorio 41
Glycation gap : an additional tool for glycometabolic monitoring 39
Re-thinking diabetic nephropathy: Microalbuminuria is just a piece of the diagnostic puzzle 29
Performance evaluation of Arkray HA-8190V system for measuring glycated hemoglobin 27
Why glycated albumin decreases in pregnancy? Evidences from a prospective study on physiological pregnancies of Caucasian women 26
Hb Agenogi [beta 90(F6)Glu-->Lys] identified by DNA analysis 20
Progressive Thinning of Retinal Nerve Fiber Layer/Ganglion Cell Layer (RNFL/GCL) as Biomarker and Pharmacological Target of Diabetic Retinopathy 19
Analysis of annual distributions of hemoglobin A2 values as a method to test for HbA2 standardization 16
Reference intervals for glycated albumin during physiological pregnancy of Europid women: Evidences from a prospective observational study 14
Screening for sickle cell disease: focus on newborn investigations 1
Totale 9.306
Categoria #
all - tutte 24.409
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.409


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020843 0 0 0 63 64 145 103 55 180 149 60 24
2020/2021873 28 43 68 31 90 66 68 44 95 54 226 60
2021/2022875 67 51 33 37 82 44 81 55 89 88 86 162
2022/20231.235 183 57 91 116 117 247 67 73 134 25 86 39
2023/2024801 43 58 44 63 159 77 39 45 39 30 99 105
2024/2025506 98 207 74 127 0 0 0 0 0 0 0 0
Totale 9.306